• 1
    Vigneron, N. and Van den Eynde, B. J., Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes. Cell. Mol. Life Sci. 2011. 68: 15031520.
  • 2
    Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F. et al., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 1995. 154: 39613968.
  • 3
    Zarour, H., De Smet, C., Lehmann, F., Marchand, M., Lethé, B., Romero, P., Boon, T. et al., The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. J. Invest. Dermatol. 1996. 107: 6367.
  • 4
    Germeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F. et al., High frequency of anti-tumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J. Exp. Med. 2005. 201: 241248.
  • 5
    Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. et al., Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994. 78: 761771.
  • 6
    Peaper, D. R. and Cresswell, P., Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 2008. 24: 343368.
  • 7
    DiBrino, M., Parker, K. C., Margulies, D. H., Shiloach, J., Turner, R. V., Biddison, W. E. and Coligan, J. E., Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry 1995. 34: 1013010138.
  • 8
    Hérin, M., Lemoine, C., Weynants, P., Vessière, F., Van Pel, A., Knuth, A., Devos, R. et al., Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer 1987. 39: 390396.
  • 9
    Rock, K. L. and Goldberg, A. L., Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 1999. 17: 739779.
  • 10
    Zernich, D., Purcell, A. W., Macdonald, W. A., Kjer-Nielsen, L., Ely, L. K., Laham, N., Crockford, T. et al., Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. 2004. 200: 1324.
  • 11
    Praveen, P. V., Yaneva, R., Kalbacher, H. and Springer, S., Tapasin edits peptides on MHC class I molecules by accelerating peptide exchange. Eur. J. Immunol. 2010. 40: 214224.
  • 12
    Williams, A. P., Peh, C. A., Purcell, A. W., McCluskey, J. and Elliott, T., Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 2002. 16: 509520.
  • 13
    Dick, T. P., Bangia, N., Peaper, D. R. and Cresswell, P., Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 2002. 16: 8798.
  • 14
    Chiari, R., Foury, F., De Plaen, E., Baurain, J.-F., Thonnard, J. and Coulie, P. G., Two antigens recognized by autologous CTL on a melanoma result from a single point mutation in an essential housekeeping gene. Cancer Res. 1999. 59: 57855792.
  • 15
    Tussey, L. G. and Frelinger, J. A., Detergent enhances binding of a secreted HLA-A2 molecule to solid phase peptides. Hum. Immunol. 1991. 32: 183193.
  • 16
    Stryhn, A., Pedersen, L. O., Romme, T., Olsen, A. C., Nissen, M. H., Thorpe, C. J. and Buus, S., pH dependence of MHC class I-restricted peptide presentation. J. Immunol. 1996. 156: 41914197.
  • 17
    Leonhardt, R. M., Keusekotten, K., Bekpen, C. and Knittler, M. R., Critical role for the tapasin-docking site of TAP2 in the functional integrity of the MHC class I-peptide-loading complex. J. Immunol. 2005. 175: 51045114.
  • 18
    Ojcius, D. M., Gapin, L. and Kourilsky, P., Dissociation of the peptide/MHC class I complex: pH dependence and effect of endogenous peptides on the activation energy. Biochem. Biophys. Res. Commun. 1993. 197: 12161222.
  • 19
    Gromme, M., Uytdehaag, F. G., Janssen, H., Calafat, J., van Binnendijk, R. S., Kenter, M. J., Tulp, A. et al., Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. USA 1999. 96: 1032610331.
  • 20
    Mantegazza, A. R., Savina, A., Vermeulen, M., Perez, L., Geffner, J., Hermine, O., Rosenzweig, S. D. et al., NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 2008. 112: 47124722.
  • 21
    Ojcius, D. M., Abastado, J. P., Casrouge, A., Mottez, E., Cabanie, L. and Kourilsky, P., Dissociation of the peptide-MHC class I complex limits the binding rate of exogenous peptide. J. Immunol. 1993. 151: 60206026.
  • 22
    Vigneron, N., Peaper, D. R., Leonhardt, R. M. and Cresswell, P., Functional significance of tapasin membrane association and disulfide linkage to ERp57 in MHC class I presentation. Eur. J. Immunol. 2009. 39: 23712376.
  • 23
    Luiten, R. M., Demotte, N., Tine, J. and van der Bruggen, P., A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules. Tissue Antigens 2000. 56: 7781.
  • 24
    Williams, A. P., Bevan, S., Bunce, M., Houlston, R., Welsh, K. I. and Elliott, T., Identification of novel tapasin polymorphisms and linkage disequilibrium to MHC class I alleles. Immunogenetics 2000. 52: 911.
  • 25
    Pu, Z., Carrero, J. A. and Unanue, E. R., Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 2002. 99: 88448849.
  • 26
    Akatsuka, Y., Nishida, T., Kondo, E., Miyazaki, M., Taji, H., Iida, H., Tsujimura, K. et al., Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J. Exp. Med. 2003. 197: 14891500.
  • 27
    van der Bruggen, P., Stroobant, V., Vigneron, N. and Van den Eynde, B., Peptide database of T-cell defined tumor antigens 2011.
  • 28
    Sieker, F., Straatsma, T. P., Springer, S. and Zacharias, M., Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: a molecular dynamics simulation study. Mol. Immunol. 2008. 45: 37143722.
  • 29
    Leonhardt, R. M., Fiegl, D., Rufer, E., Karger, A., Bettin, B. and Knittler, M. R., Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7. J. Immunol. 2010. 184: 29852998.
  • 30
    Lee, T. D., Distributions of HLA antigens. In Lee, J. (Ed.) The HLA System. A New Approach. Springer Verlag, New York, 1990, pp 141178.
  • 31
    Hsu, D. H., Paz, P., Villaflor, G., Rivas, A., Mehta-Damani, A., Angevin, E., Zitvogel, L. et al., Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J. Immunother. 2003. 26: 440450.
  • 32
    Greenwood, R., Shimizu, Y., Sekhon, G. S. and DeMars, R., Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B-cell line. J. Immunol. 1994. 153: 55255536.
  • 33
    Peh, C. A., Burrows, S. R., Barnden, M., Khanna, R., Cresswell, P., Moss, D. J. and McCluskey, J., HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998. 8: 531542.
  • 34
    Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C. et al., Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994. 83: 19881997.
  • 35
    Chaux, P., Luiten, R., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V. et al., Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J. Immunol. 1999. 163: 29282936.
  • 36
    Murata, M., Warren, E. H. and Riddell, S. R., A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 2003. 197: 12791289.
  • 37
    Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B. et al., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 1994. 179: 921930.
  • 38
    Seed, B. and Aruffo, A., Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 1987. 84: 33653369.
  • 39
    Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L. et al., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992. 35: 145152.
  • 40
    Mulder, A., Kardol, M. J., Arn, J. S., Eijsink, C., Franke, M. E., Schreuder, G. M., Haasnoot, G. W. et al., Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. Mol. Immunol. 2010. 47: 809815.
  • 41
    Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P. et al., An antigenic peptide produced by peptide splicing in the proteasome. Science 2004. 304: 587590.